Search
Bradykinin
go.drugbank.com/drugs/DB12126InvestigationalBradykinin has been investigated for the basic science and treatment of Hypertension and Diabetes Type 2.
Synonyms: L-bradykininKetanserin
go.drugbank.com/drugs/DB12465InvestigationalKetanserin has been investigated for the treatment of Septic Shock, Severe Sepsis, and Diabetic Foot Ulcer.
Irosustat
go.drugbank.com/drugs/DB02292InvestigationalIrosustat has been investigated for the treatment of Metastatic Breast Cancer and Locally Advanced Breast Cancer.
Glucagon
go.drugbank.com/drugs/DB00040ApprovedInvestigationalGlucagon is a 29 amino acid hormone used as a diagnostic aid in radiologic exams to temporarily inhibit the movement of the gastrointestinal tract and to treat severe hypoglycemia. … [L7640,L7643] Glucagon was granted FDA approval on 14 November 1960.[L7631]
Products: GLUCAGEN FOR INJECTION 1 mg/mlDP-VPA
go.drugbank.com/drugs/DB05821InvestigationalDP-VPA is D-Pharm's proprietary lipid modified version of valproic acid (VPA) that demonstrate that DP-VPA is well-tolerated in patients with resistant epilepsy and has a marked effect on reducing seizure
Liranaftate
go.drugbank.com/drugs/DB19985ExperimentalLiranaftate is a small molecule drug. Liranaftate has a monoisotopic molecular weight of 328.12 Da.
Categories: Antifungals for Topical Use, Antifungals for Dermatological UseOvemotide
go.drugbank.com/drugs/DB19156InvestigationalOvemotide is under investigation in clinical trial NCT00357461 (Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma).
Synonyms: Tyr-leu-glu-pro-gly-pro-val-thr-val, L-valine, l-tyrosyl-l-leucyl-l-.alpha.-glutamyl-l-prolylglycyl-l-prolyl-l-valyl-l-threonyl-Tinostamustine
go.drugbank.com/drugs/DB15147InvestigationalTinostamustine is under investigation in clinical trial NCT03452930 (Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma).
Aldoxorubicin
go.drugbank.com/drugs/DB06013InvestigationalAldoxorubicin, an antineoplastic agents, is an albumin-binding prodrug of doxorubicin.
Zatolmilast
go.drugbank.com/drugs/DB14790InvestigationalBPN-14770 is under investigation in clinical trial NCT02840279 (A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects).